×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
TXG – 10x genomics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
TXG
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/1
06:03 pm
txg
10x Genomics (NASDAQ:TXG) was given a new $20.00 price target on by analysts at Morgan Stanley.
Low
Report
10x Genomics (NASDAQ:TXG) was given a new $20.00 price target on by analysts at Morgan Stanley.
11/18
01:14 pm
txg
10x Genomics (NASDAQ:TXG) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
10x Genomics (NASDAQ:TXG) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
11/18
09:00 am
txg
New ASTRA Consortium Unites Asia-Pacific Scientists to Build Pan-Cancer Spatial Atlas Powered by 10x Genomics' Xenium
Low
Report
New ASTRA Consortium Unites Asia-Pacific Scientists to Build Pan-Cancer Spatial Atlas Powered by 10x Genomics' Xenium
11/15
11:51 pm
txg
10x Genomics Expands Flex Lineup with High-Throughput Single-Cell Assay Launch [Yahoo! Finance]
Neutral
Report
10x Genomics Expands Flex Lineup with High-Throughput Single-Cell Assay Launch [Yahoo! Finance]
11/14
08:36 am
txg
1 Momentum Stock with Promising Prospects and 2 We Avoid [Yahoo! Finance]
Low
Report
1 Momentum Stock with Promising Prospects and 2 We Avoid [Yahoo! Finance]
11/12
01:23 pm
txg
10x Genomics (NASDAQ:TXG) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
10x Genomics (NASDAQ:TXG) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
11/12
06:44 am
txg
10x Genomics (NASDAQ:TXG) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Low
Report
10x Genomics (NASDAQ:TXG) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
11/11
04:05 pm
txg
10x Genomics to Participate in the Wolfe Research Healthcare Conference 2025
Low
Report
10x Genomics to Participate in the Wolfe Research Healthcare Conference 2025
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/25
05:25 pm
txg
Form 4 10x Genomics, Inc. For: Nov 24 Filed by: Taich Adam
Low
Report
Form 4 10x Genomics, Inc. For: Nov 24 Filed by: Taich Adam
11/25
05:24 pm
txg
Form 4 10x Genomics, Inc. For: Nov 24 Filed by: Hindson Benjamin J.
Low
Report
Form 4 10x Genomics, Inc. For: Nov 24 Filed by: Hindson Benjamin J.
11/25
05:23 pm
txg
Form 4 10x Genomics, Inc. For: Nov 24 Filed by: Saxonov Serge
Low
Report
Form 4 10x Genomics, Inc. For: Nov 24 Filed by: Saxonov Serge
11/24
05:33 pm
txg
Form 144 10x Genomics, Inc. Filed by: Hindson Benjamin J.
Medium
Report
Form 144 10x Genomics, Inc. Filed by: Hindson Benjamin J.
11/24
04:56 pm
txg
Form 144 10x Genomics, Inc. Filed by: Saxonov Serge
Medium
Report
Form 144 10x Genomics, Inc. Filed by: Saxonov Serge
11/24
04:29 pm
txg
Form 144 10x Genomics, Inc. Filed by: Taich Adam
Medium
Report
Form 144 10x Genomics, Inc. Filed by: Taich Adam
11/14
06:04 am
txg
Form 8-K 10x Genomics, Inc. For: Nov 12
Low
Report
Form 8-K 10x Genomics, Inc. For: Nov 12
11/13
09:03 am
txg
Form SCHEDULE 13G/A 10x Genomics, Inc. Filed by: Amova Asset Management Americas, Inc.
Low
Report
Form SCHEDULE 13G/A 10x Genomics, Inc. Filed by: Amova Asset Management Americas, Inc.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
12/19
Form 8-K 10x Genomics, Inc. For: Dec 18
19.6%
2/27 Form 10-K 10x Genomics, Inc. For: Dec 31 9.6%
9/18 Form 3 10x Genomics, Inc. For: Sep 11 Filed by: Paladin Capital Cyber Group, LLC 8.8%
11/9 10x Genomics Inc (TXG) Q3 2019 Earnings Call Transcript [The Motley Fool] 8.2%
3/9 Form 4 10x Genomics, Inc. For: Mar 06 Filed by: CRUTCHFIELD BRADFORD 7.3%
10/25 10x Genomics to Report Third Quarter 2019 Financial Results on November 7, 2019 6.8%
12/20 10x Genomics and Care.com among Tech gainers; CalAmp and Technical Communications among losers [Seeking Alpha] 6.8%
2/14 Form 8-K 10x Genomics, Inc. For: Feb 12 6.7%
4/3 Form 4 10x Genomics, Inc. For: Apr 01 Filed by: CRUTCHFIELD BRADFORD 6.1%
4/7 Form 4 10x Genomics, Inc. For: Apr 06 Filed by: Saxonov Serge 5.7%
2/27 Form 10-K 10x Genomics, Inc. For: Dec 31 9.6%
9/18 Form 3 10x Genomics, Inc. For: Sep 11 Filed by: Paladin Capital Cyber Group, LLC 8.8%
11/9 10x Genomics Inc (TXG) Q3 2019 Earnings Call Transcript [The Motley Fool] 8.2%
3/9 Form 4 10x Genomics, Inc. For: Mar 06 Filed by: CRUTCHFIELD BRADFORD 7.3%
10/25 10x Genomics to Report Third Quarter 2019 Financial Results on November 7, 2019 6.8%
12/20 10x Genomics and Care.com among Tech gainers; CalAmp and Technical Communications among losers [Seeking Alpha] 6.8%
2/14 Form 8-K 10x Genomics, Inc. For: Feb 12 6.7%
4/3 Form 4 10x Genomics, Inc. For: Apr 01 Filed by: CRUTCHFIELD BRADFORD 6.1%
4/7 Form 4 10x Genomics, Inc. For: Apr 06 Filed by: Saxonov Serge 5.7%
TOP News Decliners
9/24
10x Genomics (NYSE: TXG) is now covered by analysts at Evercore ISI. They set an "outperform" rating on the stock.
-10.0%
2/25 10x Genomics to Present at the 40th Annual Cowen Health Care Conference -8.0%
1/30 The Daily Biotech Pulse: Novartis Earnings, Hepion's NASH Candidate Beats Rival Drugs, Annovis Bio To Debut [Yahoo! Finance News] -7.4%
3/5 10x Genomics (NYSE: TXG) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock. -6.2%
12/11 Form 8-K 10x Genomics, Inc. For: Dec 11 -5.6%
3/18 Form 3 10x Genomics, Inc. For: Sep 11 Filed by: SOFTBANK VISION FUND (AIV M2) L.P. -5.2%
12/12 Form 8-K 10x Genomics, Inc. For: Dec 12 -4.7%
9/12 Form 4 10x Genomics, Inc. For: Sep 11 Filed by: ROBERTS BRYAN E -4.1%
1/7 10x Genomics to Present at the 38th Annual J.P. Morgan Healthcare Conference -3.3%
11/26 10x Genomics Begins Shipments of Visium Spatial Gene Expression Solution -3.0%
2/25 10x Genomics to Present at the 40th Annual Cowen Health Care Conference -8.0%
1/30 The Daily Biotech Pulse: Novartis Earnings, Hepion's NASH Candidate Beats Rival Drugs, Annovis Bio To Debut [Yahoo! Finance News] -7.4%
3/5 10x Genomics (NYSE: TXG) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock. -6.2%
12/11 Form 8-K 10x Genomics, Inc. For: Dec 11 -5.6%
3/18 Form 3 10x Genomics, Inc. For: Sep 11 Filed by: SOFTBANK VISION FUND (AIV M2) L.P. -5.2%
12/12 Form 8-K 10x Genomics, Inc. For: Dec 12 -4.7%
9/12 Form 4 10x Genomics, Inc. For: Sep 11 Filed by: ROBERTS BRYAN E -4.1%
1/7 10x Genomics to Present at the 38th Annual J.P. Morgan Healthcare Conference -3.3%
11/26 10x Genomics Begins Shipments of Visium Spatial Gene Expression Solution -3.0%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: